Anhui Sunhere Pharmaceutical Excipients Co Ltd - Asset Resilience Ratio
Anhui Sunhere Pharmaceutical Excipients Co Ltd (300452) has an Asset Resilience Ratio of 31.78% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital to net assets of Anhui Sunhere Pharmaceutical Excipients to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2015–2025)
This chart shows how Anhui Sunhere Pharmaceutical Excipients Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Anhui Sunhere Pharmaceutical Excipients total assets.
Liquid Assets Composition Over Time
This chart breaks down Anhui Sunhere Pharmaceutical Excipients Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Anhui Sunhere Pharmaceutical Excipients (300452) total liabilities for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥558.43 Million | 31.78% |
| Total Liquid Assets | CN¥558.43 Million | 31.78% |
Asset Resilience Insights
- Very High Liquidity: Anhui Sunhere Pharmaceutical Excipients Co Ltd maintains exceptional liquid asset reserves at 31.78% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Anhui Sunhere Pharmaceutical Excipients Co Ltd Industry Peers by Asset Resilience Ratio
Compare Anhui Sunhere Pharmaceutical Excipients Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI |
Drug Manufacturers - Specialty & Generic | 1.54% |
|
Yunnan Baiyao Group Co Ltd
SHE:000538 |
Drug Manufacturers - Specialty & Generic | 8.38% |
|
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317 |
Drug Manufacturers - Specialty & Generic | 6.62% |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK |
Drug Manufacturers - Specialty & Generic | 4.94% |
|
Harbin Gloria Pharmaceuticals
SHE:002437 |
Drug Manufacturers - Specialty & Generic | 9.04% |
|
Jiuzhitang Co Ltd
SHE:000989 |
Drug Manufacturers - Specialty & Generic | 7.86% |
|
Renhe Pharmacy Co Ltd
SHE:000650 |
Drug Manufacturers - Specialty & Generic | 37.54% |
|
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557 |
Drug Manufacturers - Specialty & Generic | 0.29% |
Annual Asset Resilience Ratio for Anhui Sunhere Pharmaceutical Excipients Co Ltd (2015–2025)
The table below shows the annual Asset Resilience Ratio data for Anhui Sunhere Pharmaceutical Excipients Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 30.45% | CN¥521.55 Million ≈ $76.32 Million |
CN¥1.71 Billion ≈ $250.65 Million |
-2.61pp |
| 2024-12-31 | 33.06% | CN¥515.63 Million ≈ $75.45 Million |
CN¥1.56 Billion ≈ $228.24 Million |
-0.11pp |
| 2023-12-31 | 33.17% | CN¥511.77 Million ≈ $74.89 Million |
CN¥1.54 Billion ≈ $225.75 Million |
+15.00pp |
| 2022-12-31 | 18.17% | CN¥214.56 Million ≈ $31.40 Million |
CN¥1.18 Billion ≈ $172.75 Million |
-1.34pp |
| 2021-12-31 | 19.52% | CN¥187.88 Million ≈ $27.49 Million |
CN¥962.58 Million ≈ $140.86 Million |
-1.70pp |
| 2020-12-31 | 21.22% | CN¥191.14 Million ≈ $27.97 Million |
CN¥900.87 Million ≈ $131.83 Million |
+10.67pp |
| 2019-12-31 | 10.54% | CN¥85.41 Million ≈ $12.50 Million |
CN¥810.17 Million ≈ $118.55 Million |
-11.01pp |
| 2018-12-31 | 21.56% | CN¥153.00 Million ≈ $22.39 Million |
CN¥709.75 Million ≈ $103.86 Million |
+0.55pp |
| 2017-12-31 | 21.01% | CN¥140.00 Million ≈ $20.49 Million |
CN¥666.40 Million ≈ $97.52 Million |
-8.24pp |
| 2016-12-31 | 29.25% | CN¥150.00 Million ≈ $21.95 Million |
CN¥512.85 Million ≈ $75.05 Million |
+3.05pp |
| 2015-12-31 | 26.20% | CN¥120.00 Million ≈ $17.56 Million |
CN¥458.06 Million ≈ $67.03 Million |
-- |
About Anhui Sunhere Pharmaceutical Excipients Co Ltd
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. research and development, production, and sale of new pharmaceutical excipients in China. The company provides cellulose, starch, povidone, stearic acid, coating powder, resin, food additive, and other products. It also exports its products. Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. was founded in 2001 and is based in Huainan, China.